146 related articles for article (PubMed ID: 7844593)
21. Dose-intensive ifosfamide for the treatment of non-Hodgkin's lymphoma.
Vose JM
Semin Oncol; 1996 Jun; 23(3 Suppl 6):33-7. PubMed ID: 8677446
[TBL] [Abstract][Full Text] [Related]
22. Phase I study of escalating doses of paclitaxel (Taxol) with fixed doses of ifosfamide, carboplatin, and etoposide.
Boros L; Garrow GC; Asbury RF; Chang AY
Semin Oncol; 1995 Jun; 22(3 Suppl 7):28-31. PubMed ID: 7610396
[TBL] [Abstract][Full Text] [Related]
23. Phase II study of ifosfamide, carboplatin, and oral etoposide chemotherapy for extensive-disease small-cell lung cancer: an Eastern Cooperative Oncology Group pilot study.
Wolff AC; Ettinger DS; Neuberg D; Comis RL; Ruckdeschel JC; Bonomi PD; Johnson DH
J Clin Oncol; 1995 Jul; 13(7):1615-22. PubMed ID: 7602350
[TBL] [Abstract][Full Text] [Related]
24. Ifosfamide, carboplatin, and etoposide: a new regimen with a broad spectrum of activity.
Fields KK; Zorsky PE; Hiemenz JW; Kronish LE; Elfenbein GJ
J Clin Oncol; 1994 Mar; 12(3):544-52. PubMed ID: 8120552
[TBL] [Abstract][Full Text] [Related]
25. Escalating sequential high-dose carboplatin and etoposide with autologous marrow support in children with relapsed solid tumors.
Santana VM; Schell MJ; Williams R; Bowman LC; Thompson EI; Brenner MK; Mirro J
Bone Marrow Transplant; 1992 Nov; 10(5):457-62. PubMed ID: 1464010
[TBL] [Abstract][Full Text] [Related]
26. Phase I/II study of cyclophosphamide, carboplatin, and etoposide and autologous hematopoietic stem-cell transplantation with posttransplant interferon alfa-2b for patients with lymphoma and Hodgkin's disease.
Schenkein DP; Dixon P; Desforges JF; Berkman E; Erban JK; Ascensao JL; Miller KB
J Clin Oncol; 1994 Nov; 12(11):2423-31. PubMed ID: 7964959
[TBL] [Abstract][Full Text] [Related]
27. High-dose paclitaxel, cyclophosphamide, and cisplatin with autologous hematopoietic progenitor-cell support: a phase I trial.
Stemmer SM; Cagnoni PJ; Shpall EJ; Bearman SI; Matthes S; Dufton C; Day T; Taffs S; Hami L; Martinez C; Purdy MH; Arron J; Jones RB
J Clin Oncol; 1996 May; 14(5):1463-72. PubMed ID: 8622060
[TBL] [Abstract][Full Text] [Related]
28. Ifosfamide, etoposide, cytarabine, and methotrexate as salvage chemotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma.
Stamatoullas A; Fruchart C; Bastit D; Boulet D; Moncondult M; Piguet H; Tilly H
Cancer; 1996 Jun; 77(11):2302-7. PubMed ID: 8635099
[TBL] [Abstract][Full Text] [Related]
29. Ifosfamide/carboplatin/etoposide chemotherapy for metastatic breast cancer with or without autologous hematopoietic stem cell transplantation: evaluation of dose-response relationships.
Perkins JB; Fields KK; Elfenbein GJ
Semin Oncol; 1995 Jun; 22(3 Suppl 7):5-8. PubMed ID: 7610398
[TBL] [Abstract][Full Text] [Related]
30. Hematopoietic rescue after high-dose chemotherapy using autologous peripheral-blood progenitor cells or bone marrow: a randomized comparison.
Beyer J; Schwella N; Zingsem J; Strohscheer I; Schwaner I; Oettle H; Serke S; Huhn D; Stieger W
J Clin Oncol; 1995 Jun; 13(6):1328-35. PubMed ID: 7538556
[TBL] [Abstract][Full Text] [Related]
31. Dose escalation study of high-dose carboplatin and etoposide with autologous bone marrow support in patients with recurrent and refractory germ cell tumors.
Broun ER; Nichols CR; Mandanas R; Salzman D; Turns M; Hromas R; Cornetta K; Einhorn LH
Bone Marrow Transplant; 1995 Sep; 16(3):353-8. PubMed ID: 8535306
[TBL] [Abstract][Full Text] [Related]
32. Escalating doses of carboplatin with high-dose ifosfamide using autologous bone marrow as support: a phase I study.
Elias AD; Ayash LJ; Eder JP; Wheeler C; Deary J; Weissman L; Hunt M; Critchlow J; Schnipper L; Frei E
J Cancer Res Clin Oncol; 1991; 117 Suppl 4():S208-13. PubMed ID: 1795009
[TBL] [Abstract][Full Text] [Related]
33. Four-step high-dose sequential chemotherapy with double hematopoietic progenitor-cell rescue for metastatic breast cancer.
Patrone F; Ballestrero A; Ferrando F; Brema F; Moraglio L; Valbonesi M; Basta P; Ghio R; Gobbi M; Sessarego M
J Clin Oncol; 1995 Apr; 13(4):840-6. PubMed ID: 7707109
[TBL] [Abstract][Full Text] [Related]
34. The ICE regimen (ifosfamide, carboplatin, etoposide) for the treatment of germ-cell tumors and metastatic trophoblastic disease.
Lotz JP; André T; Bouleuc C; Péne F; Gattegno B; Bazelly B; Houry S; Chapiro J; Selle F; Gligorov J; Izrael V
Bone Marrow Transplant; 1996 Sep; 18 Suppl 1():S55-9. PubMed ID: 8899175
[No Abstract] [Full Text] [Related]
35. Phase I study of escalating targeted doses of carboplatin combined with ifosfamide and etoposide in children with relapsed solid tumors.
Marina NM; Rodman J; Shema SJ; Bowman LC; Douglass E; Furman W; Santana VM; Hudson M; Wilimas J; Meyer W
J Clin Oncol; 1993 Mar; 11(3):554-60. PubMed ID: 8445431
[TBL] [Abstract][Full Text] [Related]
36. High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cells.
Nademanee A; Sniecinski I; Schmidt GM; Dagis AC; O'Donnell MR; Snyder DS; Parker PM; Stein AS; Smith EP; Molina A
J Clin Oncol; 1994 Oct; 12(10):2176-86. PubMed ID: 7523609
[TBL] [Abstract][Full Text] [Related]
37. Phase I trial of dose-escalated paclitaxel and carboplatin in combination with ifosfamide and filgrastim: preliminary results.
Palackdharry CS
Semin Oncol; 1996 Jun; 23(3 Suppl 6):78-83. PubMed ID: 8677455
[TBL] [Abstract][Full Text] [Related]
38. Long-term survival of patients with recurrent or refractory germ cell tumors after high dose chemotherapy.
Beyer J; Kingreen D; Krause M; Schleicher J; Schwaner I; Schwella N; Huhn D; Siegert W
Cancer; 1997 Jan; 79(1):161-8. PubMed ID: 8988741
[TBL] [Abstract][Full Text] [Related]
39. Phase I study of escalating targeted doses of carboplatin combined with ifosfamide and etoposide in treatment of newly diagnosed pediatric solid tumors.
Marina NM; Rodman JH; Murry DJ; Shema SJ; Bowman LC; Jones DP; Furman W; Meyer WH; Pratt CB
J Natl Cancer Inst; 1994 Apr; 86(7):544-8. PubMed ID: 8133538
[TBL] [Abstract][Full Text] [Related]
40. Escalating high-dose carboplatin and autologous bone marrow transplantation in solid tumors.
Pico JL; Ibrahim A; Castagna L; Bourhis JH; Chazard M; Maraninchi D; Droz JP
Oncology; 1993 Nov; 50 Suppl 2():47-52. PubMed ID: 8233302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]